Maintenance Immunosuppression With Mycophenolate Mofetil: Long-Term Efficacy and Safety After Heart Transplantation

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2585-2588

  Dandel, M ^a   Jasaityte, R ^a   Lehmkuhl, H ^a   Knosalla, C ^a   Hetzer, R ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; THYMOCYTE ANTIBODY;

ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CORONARY ARTERY OBSTRUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; SKIN CANCER; SURVIVAL RATE;

AZATHIOPRINE; BIOPSY; CYCLOSPORINE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; PREDNISOLONE; RETROSPECTIVE STUDIES; SAFETY; SURVIVAL RATE; SURVIVORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 69149100149     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.031     Document Type: Article

References (7)

1. Halloran P.F., and Gourishankar S. Principles and overview of immunosuppression. In: Norman D.J., and Turka L.A. (Eds). Primer on Transplantation (2001), American Society of Transplantation, Mt. Laurel, NJ 87
2. Eisen H.J., Kobashigawa J., Keogh A., et al. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant 24 (2005) 517
3. Hosenpud J.D., and Bennet L.E. Mycophenolate mofetil versus azathioprine in patients surviving the initial cardiac transplant hospitalization: an analysis of the joint UNOS/ISHLT Thoracic Registry. Transplantation 72 (2001) 1662
4. McCarthy P.M., Billingham M.E., Flavin F.T., et al. Immunosuppression and rejection. In: Smith J.A., McCarthy P.M., and Sarris G.E. (Eds). The Stanford Manual of Cardiopulomonary Transplantation (1996), Futura P.C, NY 99
5. Kobashigawa J., Tobis J.M., Mentzer R.M., et al. Myocophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial. Am J Transplant 6 (2006) 993
6. O'Neill J.O., Edwards L.B., and Taylor D.O. Myocophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the Transplant Registry of the ISHLT. J Heart Transplant 25 (2006) 1186
7. th Official Adult Heart Transplant Report: 2007. J Heart Lung Transplant 8 (2007) 769